Epigenomics AG (EPGNF)
OTCMKTS · Delayed Price · Currency is USD
1.120
+0.170 (17.89%)
At close: Jul 18, 2025
Epigenomics AG Revenue
Epigenomics AG had revenue of 4.00K EUR in the half year ending June 30, 2025, a decrease of -98.03%. This brings the company's revenue in the last twelve months to 4.00K, down -97.06% year-over-year.
Revenue (ttm)
4.00K EUR
Revenue Growth
-97.06%
P/S Ratio
192.71
Revenue / Employee
1,000.00 EUR
Employees
4
Market Cap
905.36K USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 339.00K | -560.00K | -62.29% |
| Dec 31, 2022 | 899.00K | -5.30M | -85.51% |
| Dec 31, 2021 | 6.20M | 5.36M | 636.70% |
| Dec 31, 2020 | 842.00K | -283.00K | -25.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Centogene | 53.65M |
| Psychemedics | 19.69M |
| Aspira Women's Health | 9.34M |
| T2 Biosystems | 7.68M |
| Medical Imaging | 7.52M |
| ProPhase Labs | 5.06M |
| IDenta | 1.24M |
| InVitro International | 811.29K |